#USA #Leesburg #Clinical Solutions #Resonant #Labfish

Resonant Clinical Solutions Expands Its Global Offerings

Resonant Clinical Solutions, a key player in the realm of clinical solutions, has significantly expanded its global footprint through a strategic acquisition of Labfish, a prominent provider of clinical and laboratory equipment rental services based in Germany. This move is set to enhance Resonant's capability in navigating the increasingly complex landscape of clinical trials across various geographies.

Acquiring Labfish: A Strategic Move

On October 5, 2026, Resonant announced the acquisition of labfish rental solutions GmbH and its affiliated entities in the United States and the United Kingdom. Labfish, headquartered in Hamburg, Germany, specializes in renting out a broad range of laboratory equipment, including balances, freezers, refrigerators, infusion pumps, and monitors. Moreover, the company possesses industry-leading calibration expertise, which Resonant aims to leverage to improve its offerings further.

Christophe Berthoux, the CEO of Resonant Clinical Solutions, expressed that this acquisition not only enhances the company's presence in Europe but also bolsters its services in calibration and logistics, critical components of clinical study support. He stated, "The integration of Labfish into our Equipment Ancillaries business enhances our European presence and further extends our services in calibration and import/export, thus improving the quality of solutions for clinical studies that our clients depend on."

The Benefits of the Acquisition

Labfish's extensive capabilities can support clinical research centers in over 70 countries through strategic partnerships with warehouses located in Argentina, Israel, Turkey, and China. This integration positions Resonant to deal with the dynamic needs of clinical trials, providing comprehensive technical expertise during the growth of development programs in Europe and beyond.

Martin Forster, founder of Labfish, remarked, "As part of Resonant, our team can expand upon the calibration expertise and logistic services we have established over the years, allowing us to support a larger segment of the clinical trial process. We look forward to contributing our technical know-how and valuable customer relationships to Resonant."

Enhancing Clinical Study Processes

The demand for increasingly intricate clinical trial programs necessitates specialized equipment, advanced calibration, and robust logistic support that can keep pace with evolving research protocols and workflow requirements. The acquisition not only enhances Resonant's Equipment Ancillaries division but also provides European clients with a robust service portfolio and technical expertise.

With over 850 employees across the United States, the United Kingdom, and Europe, Resonant Clinical Solutions has successfully managed various aspects of the clinical supply chain and sample lifecycle for numerous life sciences companies. The company has historically supported more than 2,500 clinical studies and facilitated over 20,000 deliveries to client locations, showcasing its vital role in the clinical research landscape.

Conclusion

With this acquisition, the future looks promising for Resonant Clinical Solutions. The company aims to address the complexities of clinical supply chains by providing comprehensive global solutions that enhance scientific focus and patient care. As the company continues to evolve, its dedication to improving operational support for clinical studies will undoubtedly shape the future landscape of clinical research.

For more information, visit resonantclinical.com.